Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

p57(KIP2) control of actin cytoskeleton dynamics is responsible for its mitochondrial pro-apoptotic effect.

Kavanagh E, Vlachos P, Emourgeon V, Rodhe J, Joseph B.

Cell Death Dis. 2012 May 17;3:e311. doi: 10.1038/cddis.2012.51.

2.

The Cdk inhibitor p57(Kip2) controls LIM-kinase 1 activity and regulates actin cytoskeleton dynamics.

Vlachos P, Joseph B.

Oncogene. 2009 Nov 26;28(47):4175-88. doi: 10.1038/onc.2009.269. Epub 2009 Sep 7.

PMID:
19734939
3.

The cell cycle inhibitor p57(Kip2) promotes cell death via the mitochondrial apoptotic pathway.

Vlachos P, Nyman U, Hajji N, Joseph B.

Cell Death Differ. 2007 Aug;14(8):1497-507. Epub 2007 Apr 27.

4.

Downregulation of p57kip² promotes cell invasion via LIMK/cofilin pathway in human nasopharyngeal carcinoma cells.

Chow SE, Wang JS, Lin MR, Lee CL.

J Cell Biochem. 2011 Nov;112(11):3459-68. doi: 10.1002/jcb.23277.

PMID:
21769918
5.

A pro-apoptotic effect of the CDK inhibitor p57(Kip2) on staurosporine-induced apoptosis in HeLa cells.

Samuelsson MK, Pazirandeh A, Okret S.

Biochem Biophys Res Commun. 2002 Aug 23;296(3):702-9.

PMID:
12176039
6.

P21-activated kinase 4 regulates the cyclin-dependent kinase inhibitor p57(kip2) in human breast cancer.

Li Y, Wang D, Zhang H, Wang C, Dai W, Cheng Z, Wang G, Li F.

Anat Rec (Hoboken). 2013 Oct;296(10):1561-7. doi: 10.1002/ar.22754. Epub 2013 Jul 19.

7.

p57 kip2's role beyond Schwann cell cycle control.

Heinen A, Kremer D, Hartung HP, Küry P.

Cell Cycle. 2008 Sep 15;7(18):2781-6. Epub 2008 Sep 16.

PMID:
18769142
8.

Cyclin D- and E-dependent kinases and the p57(KIP2) inhibitor: cooperative interactions in vivo.

Gómez Lahoz E, Liegeois NJ, Zhang P, Engelman JA, Horner J, Silverman A, Burde R, Roussel MF, Sherr CJ, Elledge SJ, DePinho RA.

Mol Cell Biol. 1999 Jan;19(1):353-63.

9.

The multiple roles of the cyclin-dependent kinase inhibitory protein p57(KIP2) in cerebral cortical neurogenesis.

Tury A, Mairet-Coello G, DiCicco-Bloom E.

Dev Neurobiol. 2012 Jun;72(6):821-42. doi: 10.1002/dneu.20999. Review.

10.
11.

Distinct developmental roles of cell cycle inhibitors p57Kip2 and p27Kip1 distinguish pituitary progenitor cell cycle exit from cell cycle reentry of differentiated cells.

Bilodeau S, Roussel-Gervais A, Drouin J.

Mol Cell Biol. 2009 Apr;29(7):1895-908. doi: 10.1128/MCB.01885-08. Epub 2009 Jan 12.

12.

p57Kip2 regulates actin dynamics by binding and translocating LIM-kinase 1 to the nucleus.

Yokoo T, Toyoshima H, Miura M, Wang Y, Iida KT, Suzuki H, Sone H, Shimano H, Gotoda T, Nishimori S, Tanaka K, Yamada N.

J Biol Chem. 2003 Dec 26;278(52):52919-23. Epub 2003 Oct 6.

13.
14.

Identification of multiple cell cycle regulatory functions of p57Kip2 in human T lymphocytes.

Li G, Domenico J, Lucas JJ, Gelfand EW.

J Immunol. 2004 Aug 15;173(4):2383-91.

15.

p57(Kip2) and cancer: time for a critical appraisal.

Borriello A, Caldarelli I, Bencivenga D, Criscuolo M, Cucciolla V, Tramontano A, Oliva A, Perrotta S, Della Ragione F.

Mol Cancer Res. 2011 Oct;9(10):1269-84. doi: 10.1158/1541-7786.MCR-11-0220. Epub 2011 Aug 4. Review.

16.

CDK inhibitor p57 (Kip2) is downregulated by Akt during HER2-mediated tumorigenicity.

Zhao R, Yang HY, Shin J, Phan L, Fang L, Che TF, Su CH, Yeung SC, Lee MH.

Cell Cycle. 2013 Mar 15;12(6):935-43. doi: 10.4161/cc.23883. Epub 2013 Feb 19.

17.

Expressions of cyclin E, cyclin dependent kinase 2 and p57(KIP2) in human gastric cancer.

Liang B, Wang S, Yang X, Ye Y, Yu Y, Cui Z.

Chin Med J (Engl). 2003 Jan;116(1):20-3.

PMID:
12667381
18.

Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development.

Yan Y, Frisén J, Lee MH, Massagué J, Barbacid M.

Genes Dev. 1997 Apr 15;11(8):973-83.

19.

Supplemental Content

Support Center